Login / Signup

An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study.

Shotaro HajiKoji FujitaRyosuke OkiYusuke OsakiRyosuke MiyamotoHiroyuki MorinoSeiichi NaganoNaoki AtsutaYuki KanazawaYuki MatsumotoAtsuko ArisawaHisashi KawaiYasutaka SatoSatoshi SakaguchiKenta YagiTatsuto HamataniTatsuo KagimuraHiroaki YanagawaHideki MochizukiManabu DoyuSatomi MitsuhashiMasafumi HaradaYuishin Izumi
Published in: JMIR research protocols (2023)
DERR1-10.2196/42032.
Keyphrases
  • phase iii
  • study protocol
  • randomized controlled trial
  • minimally invasive
  • double blind
  • phase ii
  • placebo controlled
  • clinical trial
  • pet imaging
  • amyotrophic lateral sclerosis
  • cross sectional